Purpose

The purpose of this study is to test whether differences in study design influence patients’ response to treatment with medications. This is a research study in which you may receive treatment for depression with an FDA approved medication called escitalopram (Lexapro) or citalopram (Celexa). In some research studies, patients do not know whether they are receiving actual treatment (such as a medication) or an inactive pill (“placebo”). In other studies patients are told they are receiving the actual medication. These different kinds of research studies may cause patients to have different beliefs about whether they will improve as a result of the study. Such different beliefs may affect how patients actually do in the study and may confuse comparisons researchers make between different studies.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: 
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Blood Samples

Eligibility

Ages Eligible for Study: 18 Years - 65 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Location: 
Clinic: Mid and Late Life Depression
Division: Biological Psychiatry

Study chairs or principal investigators:
Bret R Rutherford , Principal Investigator

Co-investigators:
Steven Roose,